To investigate how the granuloma microenvironment influences the efficacy of anti-tubercular drugs, including those used clinically to treat both drug-susceptible (DS-TB) and multidrug-resistant tuberculosis, we assessed the activity of multiple agents with distinct mechanisms of action in vaccinated Nos2-deficient mice (both male and female) at two distinct stages of infection. The gene discussed is NOS2; the disease is tuberculosis.